TY - JOUR AU - Angiolillo, D. J. AU - Ueno, M. PY - 2011 DA - 2011// TI - Optimizing platelet inhibition in clopidogrel poor metabolizers: therapeutic options and practical considerations JO - JACC Cardiovasc Interv VL - 4 UR - https://doi.org/10.1016/j.jcin.2011.03.001 DO - 10.1016/j.jcin.2011.03.001 ID - Angiolillo2011 ER - TY - JOUR AU - Roffi, M. AU - Patrono, C. AU - Collet, J. -. P. AU - Mueller, C. AU - Valgimigli, M. AU - Andreotti, F. PY - 2016 DA - 2016// TI - 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevationTask force for the Management of Acute Coronary Syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) JO - Eur Heart J VL - 37 UR - https://doi.org/10.1093/eurheartj/ehv320 DO - 10.1093/eurheartj/ehv320 ID - Roffi2016 ER - TY - JOUR AU - Angiolillo, D. J. AU - Rollini, F. AU - Storey, R. F. AU - Bhatt, D. L. AU - James, S. AU - Schneider, D. J. PY - 2017 DA - 2017// TI - International expert consensus on switching platelet P2Y12 receptor-inhibiting therapies JO - Circulation VL - 136 UR - https://doi.org/10.1161/circulationaha.117.031164 DO - 10.1161/circulationaha.117.031164 ID - Angiolillo2017 ER - TY - JOUR AU - Steg, P. G. AU - James, S. K. AU - Atar, D. AU - Badano, L. P. AU - Blomstrom-Lundqvist, C. AU - Borger, M. A. PY - 2012 DA - 2012// TI - ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation JO - Eur Heart J VL - 33 UR - https://doi.org/10.1093/eurheartj/ehs215 DO - 10.1093/eurheartj/ehs215 ID - Steg2012 ER - TY - JOUR AU - Wiviott, S. D. AU - Braunwald, E. AU - McCabe, C. H. AU - Montalescot, G. AU - Ruzyllo, W. AU - Gottlieb, S. PY - 2007 DA - 2007// TI - Prasugrel versus clopidogrel in patients with acute coronary syndromes JO - N Engl J Med VL - 357 UR - https://doi.org/10.1056/NEJMoa0706482 DO - 10.1056/NEJMoa0706482 ID - Wiviott2007 ER - TY - JOUR AU - Wallentin, L. AU - Becker, R. C. AU - Budaj, A. AU - Cannon, C. P. AU - Emanuelsson, H. AU - Held, C. PY - 2009 DA - 2009// TI - Ticagrelor versus clopidogrel in patients with acute coronary syndromes JO - N Engl J Med VL - 361 UR - https://doi.org/10.1056/NEJMoa0904327 DO - 10.1056/NEJMoa0904327 ID - Wallentin2009 ER - TY - JOUR AU - Montalescot, G. AU - Sechtem, U. AU - Achenbach, S. AU - Andreotti, F. AU - Arden, C. AU - Budaj, A. PY - 2013 DA - 2013// TI - 2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European Society of Cardiology JO - Eur Heart J VL - 34 UR - https://doi.org/10.1093/eurheartj/eht296 DO - 10.1093/eurheartj/eht296 ID - Montalescot2013 ER - TY - JOUR AU - Kuliczkowski, W. AU - Witkowski, A. AU - Polonski, L. AU - Watala, C. AU - Filipiak, K. AU - Budaj, A. PY - 2009 DA - 2009// TI - Interindividual variability in the response to oral antiplatelet drugs: a position paper of the working group on antiplatelet drugs resistance appointed by the section of cardiovascular interventions of the polish cardiac society, endorsed by the working group on thrombosis of the European society of cardiology JO - Eur Heart J VL - 30 UR - https://doi.org/10.1093/eurheartj/ehn562 DO - 10.1093/eurheartj/ehn562 ID - Kuliczkowski2009 ER - TY - JOUR AU - Parodi, G. AU - Marcucci, R. AU - Valenti, R. AU - Gori, A. M. AU - Migliorini, A. AU - Giusti, B. PY - 2011 DA - 2011// TI - High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI JO - JAMA VL - 306 UR - https://doi.org/10.1001/jama.2011.1332 DO - 10.1001/jama.2011.1332 ID - Parodi2011 ER - TY - JOUR AU - Oliphant, C. S. AU - Trevarrow, B. J. AU - Dobesh, P. P. PY - 2016 DA - 2016// TI - Clopidogrel response variability: review of the literature and practical considerations JO - J Pharm Pract VL - 29 UR - https://doi.org/10.1177/0897190015615900 DO - 10.1177/0897190015615900 ID - Oliphant2016 ER - TY - JOUR AU - Ibanez, B. AU - James, S. AU - Agewall, S. AU - Antunes, M. J. AU - Bucciarelli-Ducci, C. AU - Bueno, H. PY - 2018 DA - 2018// TI - 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevationThe task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC) JO - Eur Heart J VL - 39 UR - https://doi.org/10.1093/eurheartj/ehx393 DO - 10.1093/eurheartj/ehx393 ID - Ibanez2018 ER - TY - JOUR AU - Valgimigli, M. AU - Bueno, H. AU - Byrne, R. A. AU - Collet, J. -. P. AU - Costa, F. AU - Jeppsson, A. PY - 2018 DA - 2018// TI - 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTSThe task force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS) JO - Eur Heart J VL - 39 UR - https://doi.org/10.1093/eurheartj/ehx419 DO - 10.1093/eurheartj/ehx419 ID - Valgimigli2018 ER - TY - JOUR AU - Aradi, D. AU - Storey, R. F. AU - Komocsi, A. AU - Trenk, D. AU - Gulba, D. AU - Kiss, R. G. PY - 2014 DA - 2014// TI - Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention JO - Eur Heart J VL - 35 UR - https://doi.org/10.1093/eurheartj/eht375 DO - 10.1093/eurheartj/eht375 ID - Aradi2014 ER - TY - JOUR AU - Zhang, H. AU - Zhang, P. AU - Dong, P. AU - Yang, X. AU - Wang, Y. AU - Zhang, H. PY - 2017 DA - 2017// TI - Effect of ticagrelor versus prasugrel on platelet reactivity: a meta-analysis JO - Coron Artery Dis VL - 28 UR - https://doi.org/10.1097/mca.0000000000000541 DO - 10.1097/mca.0000000000000541 ID - Zhang2017 ER - TY - JOUR AU - Lhermusier, T. AU - Lipinski, M. J. AU - Tantry, U. S. AU - Escarcega, R. O. AU - Baker, N. AU - Bliden, K. P. PY - 2015 DA - 2015// TI - Meta-analysis of direct and indirect comparison of ticagrelor and prasugrel effects on platelet reactivity JO - Am J Cardiol VL - 115 UR - https://doi.org/10.1016/j.amjcard.2014.12.029 DO - 10.1016/j.amjcard.2014.12.029 ID - Lhermusier2015 ER - TY - JOUR AU - Lemesle, G. AU - Schurtz, G. AU - Bauters, C. AU - Hamon, M. PY - 2015 DA - 2015// TI - High on-treatment platelet reactivity with ticagrelor versus prasugrel: a systematic review and meta-analysis JO - J Thromb Haemost VL - 13 UR - https://doi.org/10.1111/jth.12907 DO - 10.1111/jth.12907 ID - Lemesle2015 ER - TY - JOUR AU - Alexopoulos, D. AU - Xanthopoulou, I. AU - Storey, R. F. AU - Bliden, K. P. AU - Tantry, U. S. AU - Angiolillo, D. J. PY - 2014 DA - 2014// TI - Platelet reactivity during ticagrelor maintenance therapy: a patient-level data meta-analysis JO - Am Heart J VL - 168 UR - https://doi.org/10.1016/j.ahj.2014.06.026 DO - 10.1016/j.ahj.2014.06.026 ID - Alexopoulos2014 ER - TY - JOUR AU - Zhou, Y. AU - Wang, Y. AU - Wu, Y. AU - Huang, C. AU - Yan, H. AU - Zhu, W. PY - 2017 DA - 2017// TI - Individualized dual antiplatelet therapy based on platelet function testing in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials JO - BMC Cardiovasc Disord VL - 17 UR - https://doi.org/10.1186/s12872-017-0582-6 DO - 10.1186/s12872-017-0582-6 ID - Zhou2017 ER - TY - JOUR AU - Xu, L. AU - Hu, X. W. AU - Zhang, S. H. AU - Li, J. M. AU - Zhu, H. AU - Xu, K. PY - 2016 DA - 2016// TI - Intensified antiplatelet treatment reduces major cardiac events in patients with Clopidogrel low response: a meta-analysis of randomized controlled trials JO - Chin Med J VL - 129 UR - https://doi.org/10.4103/0366-6999.179786 DO - 10.4103/0366-6999.179786 ID - Xu2016 ER - TY - JOUR AU - Reny, J. L. AU - Fontana, P. AU - Hochholzer, W. AU - Neumann, F. J. AU - Berg, J. AU - Janssen, P. W. PY - 2016 DA - 2016// TI - Vascular risk levels affect the predictive value of platelet reactivity for the occurrence of MACE in patients on clopidogrel. Systematic review and meta-analysis of individual patient data JO - Thromb Haemost VL - 115 UR - https://doi.org/10.1160/th15-09-0742 DO - 10.1160/th15-09-0742 ID - Reny2016 ER - TY - JOUR AU - Ma, W. AU - Liang, Y. AU - Zhu, J. AU - Wang, Y. AU - Wang, X. PY - 2015 DA - 2015// TI - Meta-analysis appraising high maintenance dose clopidogrel in patients who underwent percutaneous coronary intervention with and without high on-clopidogrel platelet reactivity JO - Am J Cardiol VL - 115 UR - https://doi.org/10.1016/j.amjcard.2014.12.013 DO - 10.1016/j.amjcard.2014.12.013 ID - Ma2015 ER - TY - JOUR AU - Lin, L. AU - Wang, H. AU - Chen, Y. F. AU - Lin, W. W. AU - Wang, C. L. AU - Lin, C. H. PY - 2015 DA - 2015// TI - High maintenance dose of clopidogrel in patients with high on-treatment platelet reactivity after a percutaneous coronary intervention: a meta-analysis JO - Coron Artery Dis VL - 26 UR - https://doi.org/10.1097/mca.0000000000000246 DO - 10.1097/mca.0000000000000246 ID - Lin2015 ER - TY - JOUR AU - D'Ascenzo, F. AU - Barbero, U. AU - Bisi, M. AU - Moretti, C. AU - Omede, P. AU - Cerrato, E. PY - 2014 DA - 2014// TI - The prognostic impact of high on-treatment platelet reactivity with aspirin or ADP receptor antagonists: systematic review and meta-analysis JO - Biomed Res Int VL - 2014 UR - https://doi.org/10.1155/2014/610296 DO - 10.1155/2014/610296 ID - D'Ascenzo2014 ER - TY - JOUR AU - Chen, J. AU - Chen, S. Y. AU - Lian, J. J. AU - Zeng, X. Q. AU - Luo, T. C. PY - 2013 DA - 2013// TI - Pharmacodynamic impacts of proton pump inhibitors on the efficacy of clopidogrel in vivo--a systematic review JO - Clin Cardiol VL - 36 UR - https://doi.org/10.1002/clc.22094 DO - 10.1002/clc.22094 ID - Chen2013 ER - TY - JOUR AU - Thomas, M. R. AU - Storey, R. F. PY - 2016 DA - 2016// TI - Clinical significance of residual platelet reactivity in patients treated with platelet P2Y12 inhibitors JO - Vasc Pharmacol VL - 84 UR - https://doi.org/10.1016/j.vph.2016.05.010 DO - 10.1016/j.vph.2016.05.010 ID - Thomas2016 ER - TY - JOUR AU - Zhang, Y. AU - Zhang, S. AU - Ding, Z. PY - 2017 DA - 2017// TI - Role of P2Y12 receptor in thrombosis JO - Adv Exp Med Biol VL - 906 UR - https://doi.org/10.1007/5584_2016_123 DO - 10.1007/5584_2016_123 ID - Zhang2017 ER - TY - JOUR AU - Thomas, M. R. AU - Storey, R. F. PY - 2012 DA - 2012// TI - Optimal management of antiplatelet therapy and proton pump inhibition following percutaneous coronary intervention JO - Curr Treat Options Cardiovasc Med VL - 14 UR - https://doi.org/10.1007/s11936-011-0157-2 DO - 10.1007/s11936-011-0157-2 ID - Thomas2012 ER - TY - JOUR AU - Siller-Matula, J. M. AU - Trenk, D. AU - Schror, K. AU - Gawaz, M. AU - Kristensen, S. D. AU - Storey, R. F. PY - 2013 DA - 2013// TI - Response variability to P2Y12 receptor inhibitors: expectations and reality JO - JACC Cardiovasc Interv VL - 6 UR - https://doi.org/10.1016/j.jcin.2013.06.011 DO - 10.1016/j.jcin.2013.06.011 ID - Siller-Matula2013 ER - TY - JOUR AU - Mao, L. AU - Jian, C. AU - Changzhi, L. AU - Dan, H. AU - Suihua, H. AU - Wenyi, T. PY - 2013 DA - 2013// TI - Cytochrome CYP2C19 polymorphism and risk of adverse clinical events in clopidogrel-treated patients: a meta-analysis based on 23,035 subjects JO - Arch Cardiovasc Dis VL - 106 UR - https://doi.org/10.1016/j.acvd.2013.06.055 DO - 10.1016/j.acvd.2013.06.055 ID - Mao2013 ER - TY - JOUR AU - Pettersen, A. A. AU - Arnesen, H. AU - Opstad, T. B. AU - Seljeflot, I. PY - 2011 DA - 2011// TI - The influence of CYP 2C19*2 polymorphism on platelet function testing during single antiplatelet treatment with clopidogrel JO - Thromb J VL - 9 UR - https://doi.org/10.1186/1477-9560-9-4 DO - 10.1186/1477-9560-9-4 ID - Pettersen2011 ER - TY - JOUR AU - Mega, J. L. AU - Close, S. L. AU - Wiviott, S. D. AU - Shen, L. AU - Hockett, R. D. AU - Brandt, J. T. PY - 2009 DA - 2009// TI - Cytochrome p-450 polymorphisms and response to clopidogrel JO - N Engl J Med VL - 360 UR - https://doi.org/10.1056/NEJMoa0809171 DO - 10.1056/NEJMoa0809171 ID - Mega2009 ER - TY - JOUR AU - Simon, T. AU - Verstuyft, C. AU - Mary-Krause, M. AU - Quteineh, L. AU - Drouet, E. AU - Meneveau, N. PY - 2009 DA - 2009// TI - Genetic determinants of response to clopidogrel and cardiovascular events JO - N Engl J Med VL - 360 UR - https://doi.org/10.1056/NEJMoa0808227 DO - 10.1056/NEJMoa0808227 ID - Simon2009 ER - TY - JOUR AU - Judge, H. M. AU - Patil, S. B. AU - Buckland, R. J. AU - Jakubowski, J. A. AU - Storey, R. F. PY - 2010 DA - 2010// TI - Potentiation of clopidogrel active metabolite formation by rifampicin leads to greater P2Y12 receptor blockade and inhibition of platelet aggregation after clopidogrel JO - J Thromb Haemost VL - 8 UR - https://doi.org/10.1111/j.1538-7836.2010.03925.x DO - 10.1111/j.1538-7836.2010.03925.x ID - Judge2010 ER - TY - JOUR AU - Farid, N. A. AU - Payne, C. D. AU - Small, D. S. AU - Winters, K. J. AU - Ernest, C. S. AU - Brandt, J. T. PY - 2007 DA - 2007// TI - Cytochrome P450 3A inhibition by ketoconazole affects prasugrel and clopidogrel pharmacokinetics and pharmacodynamics differently JO - Clin Pharmacol Ther VL - 81 UR - https://doi.org/10.1038/sj.clpt.6100139 DO - 10.1038/sj.clpt.6100139 ID - Farid2007 ER - TY - JOUR AU - Park, J. S. AU - Cha, K. S. AU - Lee, H. W. AU - Oh, J. H. AU - Choi, J. H. AU - Lee, H. C. PY - 2017 DA - 2017// TI - Platelet reactivity and clinical outcomes in patients using CYP3A4-metabolized statins with clopidogrel in percutaneous coronary intervention JO - Heart Vessel VL - 32 UR - https://doi.org/10.1007/s00380-016-0927-6 DO - 10.1007/s00380-016-0927-6 ID - Park2017 ER - TY - JOUR AU - Trenk, D. AU - Hochholzer, W. AU - Frundi, D. AU - Stratz, C. AU - Valina, C. M. AU - Bestehorn, H. P. PY - 2008 DA - 2008// TI - Impact of cytochrome P450 3A4-metabolized statins on the antiplatelet effect of a 600-mg loading dose clopidogrel and on clinical outcome in patients undergoing elective coronary stent placement JO - Thromb Haemost VL - 99 UR - https://doi.org/10.1160/th07-08-0503 DO - 10.1160/th07-08-0503 ID - Trenk2008 ER - TY - JOUR AU - Franchi, F. AU - Angiolillo, D. J. PY - 2015 DA - 2015// TI - Novel antiplatelet agents in acute coronary syndrome JO - Nat Rev Cardiol VL - 12 UR - https://doi.org/10.1038/nrcardio.2014.156 DO - 10.1038/nrcardio.2014.156 ID - Franchi2015 ER - TY - JOUR AU - Siller-Matula, J. M. AU - Hintermeier, A. AU - Kastner, J. AU - Kreiner, G. AU - Maurer, G. AU - Kratochwil, C. PY - 2016 DA - 2016// TI - Distribution of clinical events across platelet aggregation values in all-comers treated with prasugrel and ticagrelor JO - Vasc Pharmacol VL - 79 UR - https://doi.org/10.1016/j.vph.2016.01.003 DO - 10.1016/j.vph.2016.01.003 ID - Siller-Matula2016 ER - TY - JOUR AU - Wiviott, S. D. AU - Trenk, D. AU - Frelinger, A. L. AU - O'Donoghue, M. AU - Neumann, F. J. AU - Michelson, A. D. PY - 2007 DA - 2007// TI - Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in comparison to Clopidogrel for inhibition of platelet activation and aggregation-thrombolysis in myocardial infarction 44 trial JO - Circulation VL - 116 UR - https://doi.org/10.1161/circulationaha.107.740324 DO - 10.1161/circulationaha.107.740324 ID - Wiviott2007 ER - TY - JOUR AU - Wallentin, L. AU - Varenhorst, C. AU - James, S. AU - Erlinge, D. AU - Braun, O. O. AU - Jakubowski, J. A. PY - 2008 DA - 2008// TI - Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease JO - Eur Heart J VL - 29 UR - https://doi.org/10.1093/eurheartj/ehm545 DO - 10.1093/eurheartj/ehm545 ID - Wallentin2008 ER - TY - JOUR AU - Friede, K. AU - Li, J. AU - Voora, D. PY - 2017 DA - 2017// TI - Use of Pharmacogenetic information in the treatment of cardiovascular disease JO - Clin Chem VL - 63 UR - https://doi.org/10.1373/clinchem.2016.255232 DO - 10.1373/clinchem.2016.255232 ID - Friede2017 ER - TY - JOUR AU - Mega, J. L. AU - Close, S. L. AU - Wiviott, S. D. AU - Shen, L. AU - Hockett, R. D. AU - Brandt, J. T. PY - 2009 DA - 2009// TI - Cytochrome P450 genetic polymorphisms and the response to prasugrel: relationship to pharmacokinetic, pharmacodynamic, and clinical outcomes JO - Circulation. VL - 119 UR - https://doi.org/10.1161/circulationaha.109.851949 DO - 10.1161/circulationaha.109.851949 ID - Mega2009 ER - TY - JOUR AU - Birkeland, K. AU - Parra, D. AU - Rosenstein, R. PY - 2010 DA - 2010// TI - Antiplatelet therapy in acute coronary syndromes: focus on ticagrelor JO - J Blood Med VL - 1 UR - https://doi.org/10.2147/jbm.s9650 DO - 10.2147/jbm.s9650 ID - Birkeland2010 ER - TY - JOUR AU - Price, M. J. AU - Berger, P. B. AU - Teirstein, P. S. AU - Tanguay, J. F. AU - Angiolillo, D. J. AU - Spriggs, D. PY - 2011 DA - 2011// TI - Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial JO - JAMA VL - 305 UR - https://doi.org/10.1001/jama.2011.290 DO - 10.1001/jama.2011.290 ID - Price2011 ER - TY - JOUR AU - Trenk, D. AU - Stone, G. W. AU - Gawaz, M. AU - Kastrati, A. AU - Angiolillo, D. J. AU - Muller, U. PY - 2012 DA - 2012// TI - A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI (testing platelet reactivity in patients undergoing elective stent placement on Clopidogrel to guide alternative therapy with Prasugrel) study JO - J Am Coll Cardiol VL - 59 UR - https://doi.org/10.1016/j.jacc.2012.02.026 DO - 10.1016/j.jacc.2012.02.026 ID - Trenk2012 ER - TY - JOUR AU - Collet, J. P. AU - Cuisset, T. AU - Range, G. AU - Cayla, G. AU - Elhadad, S. AU - Pouillot, C. PY - 2012 DA - 2012// TI - Bedside monitoring to adjust antiplatelet therapy for coronary stenting JO - N Engl J Med VL - 367 UR - https://doi.org/10.1056/NEJMoa1209979 DO - 10.1056/NEJMoa1209979 ID - Collet2012 ER - TY - JOUR AU - Cayla, G. AU - Cuisset, T. AU - Silvain, J. AU - Leclercq, F. AU - Manzo-Silberman, S. AU - Saint-Etienne, C. PY - 2016 DA - 2016// TI - Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome (ANTARCTIC): an open-label, blinded-endpoint, randomised controlled superiority trial JO - Lancet VL - 388 UR - https://doi.org/10.1016/s0140-6736(16)31323-x DO - 10.1016/s0140-6736(16)31323-x ID - Cayla2016 ER - TY - JOUR AU - Levine, G. N. AU - Bates, E. R. AU - Blankenship, J. C. AU - Bailey, S. R. AU - Bittl, J. A. AU - Cercek, B. PY - 2011 DA - 2011// TI - 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines and the Society for Cardiovascular Angiography and Interventions JO - Circulation VL - 124 UR - https://doi.org/10.1161/CIR.0b013e31823ba622 DO - 10.1161/CIR.0b013e31823ba622 ID - Levine2011 ER -